|
시장보고서
상품코드
2053035
HIV 진단 검사 시장 : 제품 유형별, 검사 유형별, 최종사용자별, 지역별HIV Diagnostics Test Market, By Product, By Test Type, By End User, By Geography |
||||||
가격
※ 부가세 별도
한글목차
영문목차
※ 본 상품은 영문 자료로 한글과 영문 목차에 불일치하는 내용이 있을 경우 영문을 우선합니다. 정확한 검토를 위해 영문 목차를 참고해주시기 바랍니다.
HIV 진단 검사 시장은 2026년에 53억 3,000만 달러로 추정되며, 2033년까지 101억 2,000만 달러에 달할 것으로 예상됩니다. 2026년부터 2033년까지 CAGR 9.6%로 성장할 것으로 전망됩니다.
| 보고서 범위 | 보고서 상세 | ||
|---|---|---|---|
| 기준 연도: | 2025년 | 2026년 시장 규모: | 53억 3,000만 달러 |
| 과거 데이터 기간: | 2020-2024년 | 예측 기간: | 2026-2033년 |
| 2026년부터 2033년까지 예측 기간 CAGR: | 9.60% | 2033년 시장 규모 예측: | 101억 2,000만 달러 |
HIV 진단 검사 시장은 지난 수십 년 동안 괄목할 만한 성장을 이루었으며, 앞으로도 큰 폭의 성장이 예상됩니다. 이는 주로 전 세계적으로 HIV/AIDS 감염자 수가 증가하고 있기 때문입니다. HIV 감염을 조기에 발견하는 것은 질병의 확산을 억제하는 데 매우 중요한 역할을 할 뿐만 아니라, 적절한 시기에 치료를 시작함으로써 감염자의 삶의 질을 향상시킬 수 있습니다. 진단 기술의 발전으로 신속하고 간편하며 현장(Point-of-Care)에서 시행할 수 있는 HIV 검사 키트가 개발되어 모든 환경에서 HIV 검사 서비스의 접근성과 수검률이 향상되었습니다.
시장 역학
세계 HIV 진단 검사 시장의 성장은 전 세계 HIV/에이즈 감염 증가에 의해 주도되고 있습니다. 세계보건기구(WHO)에 따르면, 2021년에는 약 3,800만 명이 HIV와 함께 살고 있다고 합니다. HIV/AIDS 진단 및 관리에 대한 정부의 적극적인 노력과 규제도 시장 성장을 촉진하고 있습니다. 그러나 개발도상국에서의 HIV/AIDS에 대한 인식 부족과 이 질병에 대한 사회적 편견이 진단 검사의 보급을 가로막고 있습니다. 한편, 민감도를 높이고 검사 결과 확인 시간을 단축한 새로운 진단 플랫폼 개발을 위한 연구개발이 계속되고 있으며, 시장에는 많은 성장 기회가 창출되고 있습니다.
본 조사의 주요 특징
- 이 보고서는 각 부문의 잠재적 수익기회를 파악하고, 이 시장의 매력적인 투자 제안 매트릭스를 설명합니다.
- 또한 시장 촉진요인, 억제요인, 기회, 신제품 출시 및 승인, 시장 동향, 지역별 전망, 주요 기업의 경쟁 전략에 대한 중요한 인사이트를 제공합니다.
- 이 조사는 다음과 같은 매개 변수를 기반으로 세계 HIV 진단 검사 시장의 주요 기업 프로파일을 작성했습니다. 구체적으로는 기업 하이라이트, 제품 포트폴리오, 주요 하이라이트, 재무 실적, 전략 등입니다.
- 이 보고서의 내용을 통해 기업의 마케팅 담당자와 경영진은 향후 제품 출시, 제품 업그레이드, 시장 확대, 마케팅 전략에 대한 정보에 입각한 의사결정을 내릴 수 있을 것으로 기대됩니다.
- 이 세계 HIV 진단 검사 시장 보고서는 투자자, 공급업체, 제품 제조업체, 유통업체, 신규 진입자, 재무 분석가 등 업계의 다양한 이해관계자를 대상으로 합니다.
- 이해관계자들은 세계 HIV 진단 검사 시장 분석에 사용되는 다양한 전략 매트릭스를 통해 의사결정을 쉽게 내릴 수 있을 것입니다.
목차
제1장 조사 목적과 가정
제2장 시장 전망
제3장 시장 역학·규제·동향 분석
제4장 HIV 진단 검사 시장 : 제품별, 2021-2033년
제5장 HIV 진단 검사 시장 : 테스트 유형별, 2021-2033년
제6장 HIV 진단 검사 시장 : 최종사용자별, 2021-2033년
제7장 HIV 진단 검사 시장 : 지역별, 2021-2033년
제8장 경쟁 구도
제9장 애널리스트의 견해
제10장 참고문헌 및 조사 방법
KSM 26.06.17HIV Diagnostics Test Market is estimated to be valued at USD 5.33 Bn in 2026 and is expected to reach USD 10.12 Bn by 2033, growing at a compound annual growth rate (CAGR) of 9.6% from 2026 to 2033.
| Report Coverage | Report Details | ||
|---|---|---|---|
| Base Year: | 2025 | Market Size in 2026: | USD 5.33 Bn |
| Historical Data for: | 2020 To 2024 | Forecast Period: | 2026 To 2033 |
| Forecast Period 2026 to 2033 CAGR: | 9.60% | 2033 Value Projection: | USD 10.12 Bn |
The HIV diagnostics test market has seen significant growth over the past few decades and is expected to grow substantially going forward. This is mainly due to the rise in number of people impacted by HIV/AIDS globally. Early detection of HIV infection plays a vital role in controlling the spread of the disease as well as improves the quality of life of infected individuals with timely treatment initiation. Advancements in diagnostic technologies have enabled development of rapid, simple, and point-of-care HIV testing kits which have improved accessibility and uptake of HIV testing services across all settings.
Market Dynamics
The global HIV diagnostics test market growth is driven by the rising prevalence of HIV/AIDS infections worldwide. According to WHO, around 38 million people were living with HIV in 2021. Favorable government initiatives and regulations regarding HIV/AIDS diagnosis & management also boost the market growth. However, lack of awareness about HIV/AIDS in developing nations and social stigma associated with the disease hamper widespread adoption of diagnostic tests. On the other hand, ongoing R&D towards development of novel diagnostic platforms with enhanced sensitivity and shorter turn-around-time presents multiple growth opportunities in the market.
Key Features of the Study
- It elucidates potential revenue opportunities across different segments and explains attractive investment proposition matrices for this market.
- This study also provides key insights about market drivers, restraints, opportunities, new product launches or approval, market trends, regional outlook, and competitive strategies adopted by key players.
- It profiles key players in the global HIV diagnostics test market based on the following parameters - company highlights, products portfolio, key highlights, financial performance, and strategies.
- Key companies covered as a part of this study includes Abbott, Bio-Rad Laboratories Inc., Hologic Inc., Siemens Healthineers, F. Hoffmann-La Roche Ltd., Beckman Coulter Inc., OraSure Technologies Inc., Becton Dickinson and Company, Merck KGaA, Chembio Diagnostic Systems Inc., Zyomyx Incorporation, Bristol -Myers Squibb, Janssen Pharmaceutica NV, QIAGEN N.V., and ViiV Healthcare Ltd.
- Insights from this report would allow marketers and the management authorities of the companies to make informed decisions regarding their future product launches, type up-gradation, market expansion, and marketing tactics.
- The global HIV diagnostics test market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts.
- Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the global HIV diagnostics test market.
Market Segmentation
- Product
- Assay Kit
- Consumables
- Test Type (Revenue, USD Bn, 2021 - 2033)
- Antibody Test
- Antigen/antibody tests
- Nucleic Acid Test
- End User
- Hospitals & Clinics
- Diagnostic Laboratories
- Homecare Settings
- Others
- Regional Insights (Revenue, USD Bn, 2021 - 2033)
- North America
- U.S.
- Canada
- Latin America
- Brazil
- Argentina
- Mexico
- Rest of Latin America
- Europe
- Germany
- U.K.
- Spain
- France
- Italy
- Russia
- Rest of Europe
- Asia Pacific
- China
- India
- Japan
- Australia
- South Korea
- ASEAN
- Rest of Asia Pacific
- Middle East
- GCC Countries
- Israel
- Rest of Middle East
- Africa
- South Africa
- North Africa
- Central Africa
- Company Profiles
- Abbott
- Bio-Rad Laboratories Inc.
- Hologic Inc.
- Siemens Healthineers
- F. Hoffmann-La Roche Ltd.
- Beckman Coulter Inc.
- OraSure Technologies Inc.
- Becton Dickinson and Company
- Merck KGaA
- Chembio Diagnostic Systems Inc.
- Zyomyx Incorporation
- Bristol -Myers Squibb
- Janssen Pharmaceutica NV
- QIAGEN N.V.
- ViiV Healthcare Ltd.
Table of Contents
1. Research Objectives and Assumptions
- Research Objectives
- Assumptions
- Abbreviations
2. Market Purview
- Report Description
- Market Definition and Scope
- Executive Summary
- Market Snapshot, By Product
- Market Snapshot, By Test Type
- Market Snapshot, By End User
- Market Snapshot, By Region
- Coherent Opportunity Map (COM)
3. Market Dynamics, Regulations, and Trends Analysis
- Market Dynamics
- Drivers
- Restraints
- Market Opportunities
- Impact Analysis
- Market Trends
- Recent Developments
- Acquisitions and Partnerships Scenario
- Technology Overview
- Regulatory Scenario
- PEST Analysis
4. HIV Diagnostics Test Market, By Product, 2021 - 2033, (USD BN)
- Overview
- Market Share Analysis, 2026 and 2033 (%)
- Y-o-Y Growth Analysis, 2021 - 2033
- Segment Trends
- Assay Kit
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD BN)
- Consumables
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD BN)
5. HIV Diagnostics Test Market, By Test Type, 2021 - 2033, (USD BN)
- Overview
- Market Share Analysis, 2026 and 2033 (%)
- Y-o-Y Growth Analysis, 2021 - 2033
- Segment Trends
- Antibody Test
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD BN)
- Antigen/antibody tests
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD BN)
- Nucleic Acid Test
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD BN)
6. HIV Diagnostics Test Market, By End User, 2021 - 2033, (USD BN)
- Overview
- Market Share Analysis, 2026 and 2033 (%)
- Y-o-Y Growth Analysis, 2021 - 2033
- Segment Trends
- Hospitals & Clinics
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD BN)
- Diagnostic Laboratories
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD BN)
- Homecare Settings
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD BN)
- Others
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD BN)
7. HIV Diagnostics Test Market, By Region, 2021 - 2033, (USD BN)
- Introduction
- Market Share Analysis, By Region, 2026 and 2033 (%)
- Y-o-Y Growth Analysis, For Regions, 2021 - 2033
- Regional Trends
- North America
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Product, 2021 - 2033, (USD BN)
- Market Size and Forecast, and Y-o-Y Growth, By End User, 2021 - 2033, (USD BN)
- Market Size and Forecast, and Y-o-Y Growth, By Test Type, 2021 - 2033, (USD BN)
- Market Size and Forecast, and Y-o-Y Growth, By Country, 2021 - 2033, (USD BN)
- U.S.
- Canada
- Latin America
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Product, 2021 - 2033, (USD BN)
- Market Size and Forecast, and Y-o-Y Growth, By End User, 2021 - 2033, (USD BN)
- Market Size and Forecast, and Y-o-Y Growth, By Test Type, 2021 - 2033, (USD BN)
- Market Size and Forecast, and Y-o-Y Growth, By Country, 2021 - 2033, (USD BN)
- Brazil
- Mexico
- Argentina
- Rest of Latin America
- Europe
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Product, 2021 - 2033, (USD BN)
- Market Size and Forecast, and Y-o-Y Growth, By End User, 2021 - 2033, (USD BN)
- Market Size and Forecast, and Y-o-Y Growth, By Test Type, 2021 - 2033, (USD BN)
- Market Size and Forecast, and Y-o-Y Growth, By Country, 2021 - 2033, (USD BN)
- U.K.
- Germany
- Italy
- France
- Spain
- Russia
- Rest of Europe
- Asia Pacific
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Product, 2021 - 2033, (USD BN)
- Market Size and Forecast, and Y-o-Y Growth, By End User, 2021 - 2033, (USD BN)
- Market Size and Forecast, and Y-o-Y Growth, By Test Type, 2021 - 2033, (USD BN)
- Market Size and Forecast, and Y-o-Y Growth, By Country, 2021 - 2033, (USD BN)
- China
- India
- Japan
- ASEAN
- Australia
- South Korea
- Rest of Asia Pacific
- Middle East
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Product, 2021 - 2033, (USD BN)
- Market Size and Forecast, and Y-o-Y Growth, By End User, 2021 - 2033, (USD BN)
- Market Size and Forecast, and Y-o-Y Growth, By Test Type, 2021 - 2033, (USD BN)
- Market Size and Forecast, and Y-o-Y Growth, By Country, 2021 - 2033, (USD BN)
- GCC
- Israel
- Rest of Middle East
- Africa
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Product, 2021 - 2033, (USD BN)
- Market Size and Forecast, and Y-o-Y Growth, By End User, 2021 - 2033, (USD BN)
- Market Size and Forecast, and Y-o-Y Growth, By Test Type, 2021 - 2033, (USD BN)
- Market Size and Forecast, and Y-o-Y Growth, By Country/Region, 2021 - 2033, (USD BN)
- North Africa
- Central Africa
- South Africa
8. Competitive Landscape
- Abbott
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Market Strategies
- Bio-Rad Laboratories Inc.
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Market Strategies
- Hologic Inc.
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Market Strategies
- Siemens Healthineers
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Market Strategies
- F. Hoffmann-La Roche Ltd.
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Market Strategies
- Beckman Coulter Inc.
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Market Strategies
- OraSure Technologies Inc.
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Market Strategies
- Becton Dickinson and Company
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Market Strategies
- Merck KGaA
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Market Strategies
- Biosynex SA
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Market Strategies
- Zyomyx Incorporation
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Market Strategies
- Bristol -Myers Squibb
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Market Strategies
- Janssen Pharmaceutica NV
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Market Strategies
- QIAGEN N.V.
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Market Strategies
- ViiV Healthcare Ltd.
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Market Strategies
9. Analyst View
- Wheel of Fortune
- Analyst View
- Coherent Opportunity Map
10. References and Research Methodology
- References
- Research Methodology
- About us and Sales Contact
